相关实验视频

Updated: Jun 14, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

在帕金森病的创新技术为基础的干预措施:一个系统的审查和元分析

Chun En Yau^1,2, Eric Chi Kiat Ho^1,2, Natasha Yixuan Ong^1,2

¹Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Annals of clinical and translational neurology

|September 5, 2024

概括

虚拟现实 (VR) 和自感干预措施在改善帕金森病 (PD) 运动症状和生活质量方面表现有前途. 这些基于新技术的新型治疗方法为患者提供了有效的管理选择.

科学领域:

神经学神经学
康复科学康复科学康复科学
生物医学工程生物医学工程

背景情况:

正在探索基于新技术的干预措施,包括虚拟现实 (VR) 培训,机器人辅助和生物反,以提高帕金森病 (PD) 的运动功能和步态.
这些新兴治疗方法对PD症状管理的比较有效性仍然不完全理解,需要严格分析.

研究的目的:

进行贝叶斯网络元分析,评估基于技术的干预措施对改善帕金森病 (PD) 运动症状和生活质量 (QoL) 的有效性.

主要方法:

进行了主要数据库 (Medline,Embase,Cochrane CENTRAL,Clinicaltrials.gov) 的系统搜索,其中仅包括到2024年4月2日发表的随机对照试验 (RCT).
评估的关键结果包括运动功能的变化 (UPDRS-III/MDS-UPDRS-III),步态参数 (脚步长度,10米步行测试,定时起步),平衡和质量水平.
使用贝叶斯网络元分析合成结果,报告平均差异 (MD) 或标准化平均差异 (SMD) 以95%可信区间 (95% CrI).

主要成果:

该分析包括51个RCT,涉及2095名患者. 虽然所有干预措施都对UPDRS运动分数具有相似的有效性,但虚拟现实 (VR) 干预措施在改善定时启动 (TUG) 测试方面最有效.
与对照组相比,自主感应干预显著提高了步伐长度,超过了VR,机器人和运动干预.
与对照剂和其他干预剂相比,VR干预剂在平衡尺度得分和生活质量 (QoL) 中显著改善.

结论:

基于虚拟现实 (VR) 和自身感知干预措施成为最有前途的治疗方法,在帕金森病 (PD) 的多种结果指标中始终排名最高.
这些干预措施具有很大的潜力,可以融入临床实践,有效地管理运动症状,改善PD患者的生活质量.

更多相关视频

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease

Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease

Published on: June 16, 2023

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...